Key details
Sponsor
Industrial Farmacéutica Cantabria, S.A.
Enrollment target
~45 participants
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 45 Years
Last updated February 2025